October 15, 2026 at 08:25 PM UTC
Frazier Life Sciences Acquisition Corp. II reports material agreement in SEC 8-K
Frazier Life Sciences Acquisition Corp. II filed an 8-K covering a material definitive agreement, an unregistered sale of equity securities, charter, bylaw or fiscal-year changes, and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 15, 2026 at 08:23 PM UTC
Open official source